Since basal-like breast cancer accounts for approximately 70% of TNBCs, we then analyzed GATA3 protein levels in the Clinical Proteomic Tumor Analysis Consortium (CPTAC) breast cancer patient sample set and GATA3 mRNA levels in TCGA breast cancer patient samples 47, 48 according to major clinical subclass. The gene discussed is GATA3; the disease is neoplasm.